Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis

BACKGROUND & AIMS: Application of nucleoside analogues and hepatitis B immunoglobulin (HBIG) has reduced hepatitis B virus (HBV) recurrence rate after liver transplantation (LT) dramatically. Recent data suggests therapy without HBIG is also effective. We sought to evaluate the necessity of HBIG...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peijie, Tam, Ngalei, Wang, Haochen, Zheng, Huanwei, Chen, Philip, Wu, Linwei, He, Xiaoshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125198/
https://www.ncbi.nlm.nih.gov/pubmed/25102072
http://dx.doi.org/10.1371/journal.pone.0104480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125198/
https://www.ncbi.nlm.nih.gov/pubmed/25102072
http://dx.doi.org/10.1371/journal.pone.0104480

Ejemplares similares